海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
- Hemophilia A;Hemophilia A
- Australia, Brazil, Canada, Denmark, France, Germany, Ireland, Italy, Netherlands, New Zealand, Poland, Spain, Sweden, United Kingdom, United States
- 2014-08-29
Not recruiting
- Phase 1 Study of LOP628 in Adult Patients With cKit-positive Solid Tumors and Acute Myeloid Leukemia
- cKIT-positive Solid Tumors;AML
- Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United States
- 2014-08-08
Not Recruiting
- This clinical trial is to study Immune Tolerance Induction, by Factor VIII concentrate containing von Willebrand factor, in severe or moderate haemophilia A patients with inhibitors.
- Severe or moderate haemophilia A patients with inhibitors.
- Egypt, India
- 2014-07-18
Not recruiting
- N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan
- Neuroblastoma
- Australia, Canada, United States
- 2014-01-02
Not Recruiting
- A clinical study involving people with severe haemophilia A to look at how two different strengths of an experimental replacement factor VIII protein (known as rFVIIIFc) are processed by the body and how safe it is to take.
- Hemophilia A MedDRA version: 18.0 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 100000004850 MedDRA version: 18.0 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, South Africa, United Kingdom, United States
- 2013-12-06
Not recruiting
- Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
- Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma;Tuberous Sclerosis;Subependymal Giant Cell Astrocytoma
- Australia, Belgium, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, United Kingdom, United States
- 2008-11-12
Not Recruiting
- Research for biomarkers of serum/CSF in patients with rapidly progressive dementia including human prion disease
- rapidly progressive dementia including human prion disease
- Asia(except Japan), Australia, Europe, Japan, North America, South America
- 2015-04-01
Not Recruiting
- A Study to evaluate the Efficacy and Safety of Insulin Detemir against Insulin NPH along With Metformin and Diet/Exercise in Children and Adolescents having Type 2 Diabetes
- Type 2 diabetes mellitus
- Argentina, Australia, Belgium, Brazil, Canada, China, Croatia, Denmark, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Poland, Republic of Korea, Russian Federation, Serbia, South Africa, Spain, Taiwan, The former Yugoslav Republic of Macedonia, Turkey, United Kingdom, United States of America
- 2015-02-16
Not Recruiting
- A PHASE III, RANDOMISED, DOUBLE-BLIND, MULTICENTRE, PARALLEL-GROUP, NON-INFERIORITY STUDY EVALUATING THE EFFICACY, SAFETY, AND TOLERABILITY OF DOLUTEGRAVIR PLUS LAMIVUDINE COMPARED TO DOLUTEGRAVIR PLUS TENOFOVIR/EMTRICITABINE IN HIV-1-INFECTED TREATMENT-NAÏVE ADULTS
- -B24 Unspecified human immunodeficiency virus [HIV] disease Unspecified human immunodeficiency virus [HIV] disease;Unspecified human immunodeficiency virus [HIV] disease
- Argentina, Australia, Belgium, Canada, France, Germany, Italy, Mexico, Poland, Portugal, Romania, Russian Federation, South Africa, Spain, Switzerland, Taiwan, Ukraine, United Kindgdom, United States
- 2016-12-19
Not recruiting
- A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification
- Diabetes;Diabetes Mellitus, Type 2
- Algeria, Czech Republic, Czechia, India, Russian Federation, Serbia, Turkey, United States
- 2016-09-15
Not recruiting
- Stepping Up Study: A Cluster Randomised Controlled Trial of team-based transition to insulin in primary care compared to usual care to improve HbA1c for patients with poorly controlled type 2 diabetes
- Type 2 diabetes (T2D)
- Australia
- 2012-09-25
Not Recruiting
- A Study to test the Safety and Effectiveness of the Sitagliptin in Patients with Type 2 Diabetes Mellitus who are unable to Control their Blood Sugar Levels on Insulin with or without Metformin.
- Type 2 diabetes mellitus without complications
- Australia, Belgium, Brazil, Canada, Denmark, France, Germany, Guatemala, Hungary, India, Ireland, Israel, Italy, Lithuania, Mexico, New Zealand, Norway, Peru, Poland, Portugal, Russian Federation, South Africa, Spain, Turkey, United Kingdom, United States of America
- 2012-08-03
Not recruiting
- Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
- Hemophilia A;Hemophilia A;Hemophilia A;Hemophilia A
- Australia, Hong Kong, Ireland, Netherlands, Poland, South Africa, United Kingdom, United States
- 2011-10-20
Not Recruiting
- Comparison of a new formulation of insulin glargine with Lantus in patients with type 2 diabetes mellitus on basal plus mealtime insulin
- Type 2 Diabetes Mellitus MedDRA version: 14.1 Level: PT Classification code 10067585 Term: Type 2 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Canada, Czech Republic, Estonia, Finland, Germany, Hungary, Latvia, Mexico, Netherlands, South Africa, Sweden, United States
- 2011-08-22
Not Recruiting
- Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years
- Paediatric dilated cardiomyopathy and symptomatic chronic heart failure MedDRA version: 16.0 Level: LLT Classification code 10008908 Term: Chronic heart failure System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Australia, Brazil, Denmark, Finland, Germany, Hungary, Italy, Mexico, Portugal, Russian Federation, Spain, Sweden, United Kingdom
- 2011-08-19
Not recruiting
- Risk Factors and Response to Therapy in Heart and Lung Transplant Patients with Posttransplant Lymphoproliferative Disease
- Posttransplant Lymphoproliferative Disease
- Australia
- 2013-09-30
Not recruiting
- A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Canada, France, Italy, Mexico, Portugal, Puerto Rico, Russian Federation, South Africa, Spain, Thailand, United Kingdom, United States
- 2013-07-25
Not Recruiting
- Doxycycline to improve lymphedema due to podoconiosis
- Podoconiosis (Podo) Injury, Occupational Diseases, Poisoning
- Cameroon
- 2017-07-25
Not Recruiting
- A Phase 3 study to Evaluate the Efficacy and Safety of Fitusiran in Patients with Hemophilia A or B, with Inhibitory Antibodies to Factor VIII or IX
- â?¢Hemophilia A â?¢Hemophilia B
- Australia, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, India, Israel, Italy, Japan, Malaysia, Netherlands, Portugal, Republic of Korea, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States of America
- 2018-06-29
Not recruiting
- Mobile-based Disease Management System for insulin dose adjustment in type 2 diabetes for specialist outreach and diabetes telehealth service (REMODEL-IDA): A pilot randomised controlled trial.
- Type 2 diabetes
- Australia
- 2018-03-21